Literature DB >> 135011

Intact humoral and cell-mediated immunity in chronic marijuana smoking.

G S Rachelefsky, G Opelz, M R Mickey, P Lessin, M Kiuchi, M J Silverstein, E R Stiehm.   

Abstract

The immune system of 12 healthy chronic marijuana-smoking adults was evaluated while they smoked marijuana daily for 64 consecutive days under controlled hospitalized conditions. Studies included enumeration of B and T cell subpopulations, lymphocyte proliferative responses to PHA and to allogeneic cells, and serum immunoglobulin levels. Percent B cells, initially low in 2 patients, became normal. Baseline total B cells, determined either by surface immunoglobulins (338 cells/mm3 +/- 60 SEM) or complement receptors (162 cells/mms +/- 27) were significantly (p less than 0.05) less than control but increased to normal (485 +/- 97 and 239 +/- 47) over time. Percent T cells, initially low (less than 40%) in 4 patients, became normal. Baseline T cells (951 cells/mm3 +/- 70 SEM), significantly lower than controls (2,010 +/- 210, p less than 0.05), increased to normal by day 63 (1,875 +/- 281). In vitro lymphocyte response to graded doses of PHA and to allogeneic cells was normal initially and did not change over time. Serum IgG (1,064 +/- 33), IgA (166 +/- 13), and IgM (96 +/- 6) were normal. Serum IgE levels increased in 4 subjects without evidence of allergy. Short-term chronic marijuana use does not have a substantial adverse effect on B or T cells of young healthy adults.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 135011     DOI: 10.1016/0091-6749(76)90192-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

1.  Hashish smoking and T-lymphocytes.

Authors:  E Kaklamani; D Trichopoulos; A Koutselinis; M Drouga; D Karalis
Journal:  Arch Toxicol       Date:  1978-04-27       Impact factor: 5.153

2.  Cannabinoid 2 (CB2) receptor involvement in the down-regulation but not up-regulation of serum IgE levels in immunized mice.

Authors:  Catherine A Newton; Thomas W Klein
Journal:  J Neuroimmune Pharmacol       Date:  2012-05-04       Impact factor: 4.147

3.  Metabolic and functional characteristics of alveolar macrophages recovered from rats exposed to marijuana smoke.

Authors:  D B Drath; J M Shorey; L Price; G L Huber
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

Review 4.  Marijuana: respiratory tract effects.

Authors:  Kelly P Owen; Mark E Sutter; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

5.  Allergic skin test reactivity to marijuana in the Southwest.

Authors:  G L Freeman
Journal:  West J Med       Date:  1983-06

Review 6.  Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.

Authors:  Sadiye Amcaoglu Rieder; Ashok Chauhan; Ugra Singh; Mitzi Nagarkatti; Prakash Nagarkatti
Journal:  Immunobiology       Date:  2009-05-20       Impact factor: 3.144

Review 7.  [Cannabinoids and the immune system. Of men, mice and cells].

Authors:  B Kraft; H G Kress
Journal:  Schmerz       Date:  2004-06       Impact factor: 1.107

Review 8.  Cannabinoid control of neuroinflammation related to multiple sclerosis.

Authors:  D Baker; S J Jackson; G Pryce
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

Review 9.  Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders.

Authors:  Ishtiaq Ahmed; Saif Ur Rehman; Shiva Shahmohamadnejad; Muhammad Anjum Zia; Muhammad Ahmad; Muhammad Muzammal Saeed; Zain Akram; Hafiz M N Iqbal; Qingyou Liu
Journal:  Molecules       Date:  2021-06-03       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.